Last Updated: May 10, 2026

Profile for Japan Patent: 5148115


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5148115

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Sep 28, 2026 Bristol Myers Squibb SPRYCEL dasatinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP5148115

Last updated: July 29, 2025

Introduction

Japan Patent JP5148115 pertains to a pharmaceutical invention, likely concerned with a novel drug composition, method of use, or manufacturing process, registered under the Japanese Patent Office (JPO). This analysis aims to elucidate the scope of the patent, its claims, and the broader patent landscape within which it resides. Such insights are critical for stakeholders assessing patent strength, potential freedom-to-operate, and competitive positioning in Japan’s pharmaceutical sector.


Scope of Patent JP5148115

Legal Scope Overview

The scope of JP5148115, similar to most pharmaceutical patents, encompasses the specific claims delineated within the patent specification. It extends to the protection conferred by the claims, which define the exclusive rights of the patent holder, covering either the active compound, its pharmaceutical formulation, method of manufacture, or a therapeutic application.

Technical Scope

Generally, for a drug patent, the scope includes:

  • Active Ingredient(s): Specific chemical entities or their derivatives.
  • Pharmaceutical Composition: Formulations, excipients, delivery systems.
  • Methods of Manufacturing: Synthesis pathways, purification steps.
  • Therapeutic Use: Indications, treatment regimens, dosing methods.
  • Novelty and Inventive Step Rationale: The scope hinges on these claims being novel and non-obvious over prior art.

Intended Market and Application Scope

Given the patent’s jurisdiction and class, the scope is intended to protect the drug molecule and its uses within Japan, potentially covering both proprietary formulations and treatment methods.


Claims Analysis

Claims Breakdown

The patent document contains multiple claims, typically categorized as:

  • Independent Claims: Broader, defining the core invention.
  • Dependent Claims: Narrower claims, adding specific parameters, derivatives, or methods.

Key Elements in Claims

  1. Scope of Chemical Entities
    The claims likely specify a chemical compound or a class thereof, perhaps with particular substituents or structural features conferring therapeutic advantages.

  2. Pharmaceutical Composition Claims
    These claims define specific formulations, such as tablet, injection, or transdermal patches, including excipients and dosage forms.

  3. Use Claims
    Methods of treating specific conditions — e.g., cancer, autoimmune diseases — using the compound.

  4. Manufacturing Process Claims
    Claims outlining synthesis pathways, purification steps, or novel manufacturing techniques.

Claim Language and Interpretation

In Japanese patent practice, claim language tends to be precise and technical, employing Markush structures, ranges, or Markush groups to encapsulate multiple variants. The scope depends critically on how broadly or narrowly claims are drafted. For instance:

  • A broad claim covering "a compound of formula X" versus a narrow claim specifying a particular substituent.

  • Use of functional language or ranges that can impact enforceability.

Legal and Commercial Implications

Broad independent claims afford wide protection but may face validity challenges if prior art demonstrates similar compounds or formulations. Narrower dependent claims can strengthen patent enforceability but may be circumvented by designing around.


Patent Landscape Analysis

Prior Art and Related Patents

The patent landscape features:

  • Prior Art Reference(s): Earlier patents or publications disclosing similar compounds or methods. For JP5148115 to be valid, its claims must be novel and non-obvious.

  • Related Patents: Similar patents filed within or outside Japan, indicating a crowded or sparse patent space. For example:

    • International patent applications (WO, US, EP) involving similar compounds or therapeutic uses.
    • Patents from competitors, academic institutions, or patent thickets that could influence freedom-to-operate.

Patent Family and Legal Status

  • The patent family likely includes equivalents filed in major markets (US, EU, China) to secure global rights.

  • Its legal status (granted, pending, invalidated) affects strategic decision-making.

  • Any opposition or patent office actions could have narrowed or expanded its scope.

Innovation Trends

The landscape indicates an increasing trend toward biologics or specific derivatives within the scope of the patent, aligning with global pharmaceutical trends emphasizing targeted therapies.


Strengths and Weaknesses

Strengths:

  • Specificity of Claims: Well-drafted claims with specific structural features enhance enforceability.
  • Therapeutic Scope: Covering method of use broadens protection.
  • Patent Family Strategy: A comprehensive global portfolio secures market position.

Weaknesses:

  • Potential Overbreadth: Excessively broad claims may be challenged for lack of novelty.
  • Prior Art Similarity: Existing patents may limit enforceability or open avenues for design-around.
  • Narrow Claim Language: Overly narrow claims could be circumvented more easily.

Conclusion

The Japan patent JP5148115 exemplifies a targeted approach to protecting innovative pharmaceutical assets. Its scope hinges on carefully drafted claims that balance breadth against validity, and its landscape reflects ongoing competitive and technological trends. Companies must scrutinize both the patent’s claims and associated prior art to gauge enforceability and freedom to operate.


Key Takeaways

  • Claims Determine Protection: Precise, well-constructed claims covering active compounds, formulations, and uses are vital for robust patent protection.
  • Landscape Analysis Is Critical: Understanding related patents prevents infringement risks and identifies potential licensing opportunities.
  • Global Strategy Matters: Filing corresponding patents internationally expands market protection but requires navigating varying legal standards.
  • Regular Monitoring: Patent status and legal challenges can alter the scope and enforceability over time.
  • Alignment with Innovation Trends: Patents reflecting current therapeutic and technological developments optimize commercial value.

FAQs

1. What is the primary significance of the claims in patent JP5148115?
Claims define the scope of legal protection, outlining the specific compounds, formulations, or methods covered by the patent, thus determining infringement risks and licensing potential.

2. How does the patent landscape affect the enforceability of JP5148115?
A crowded landscape with similar patents may lead to increased validity challenges, but a well-drafted, specific patent can stand resilient, provided prior art is carefully navigated.

3. Can this patent prevent competitors from developing similar drugs?
Yes, if claims are sufficiently broad and valid, they can restrict competitors from commercializing similar compounds or uses within Japan.

4. How important is geographic coverage for this patent?
Extending patent protection beyond Japan through international applications (PCT, direct filings) ensures global market exclusivity, crucial for high-value pharmaceuticals.

5. What strategies can firms employ to strengthen patent protection in this field?
Firms should pursue comprehensive patent families, draft precise claims, and continuously monitor legal developments and prior art landscapes to maintain enforceability.


Sources

[1] Japanese Patent Office (JPO) Patent Gazette, JP5148115, available from the JPO database.
[2] Patent landscape reports on pharmaceutical patents in Japan.
[3] Current trends in patent drafting and claim strategies for pharmaceuticals.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.